Company Monitoring Page for Teva-Pharmaceutical

latest headlines for company on cafepharma

Teva clears submission hurdle for Huntington's drug
BioPharma Dive
Fri, 10/21/16 - 11:28 am
Tags:
Teva Pharmaceutical, Huntington's disease, chorea, SD-809, FDA
FDA places Regeneron and Teva's pain-drug study on hold
Yahoo/Reuters
Mon, 10/17/16 - 11:56 am
Tags:
FDA, Regeneron, Teva Pharmaceutical, lower back pain, fasinumab, clinical trials
Teva Rolls Out Birth Control Rajani, Generic of Bayer's Beyaz
Investopedia
Sat, 10/15/16 - 12:21 pm
Tags:
Teva Pharmaceutical, birth control pill, contraceptives, generics, Bayer, Rajani, Beyaz
Teva ponies up $160M-plus for marketing rights to Celltrion's Rituxan, Herceptin biosims
Fierce Pharma
Fri, 10/7/16 - 09:11 am
Tags:
Teva Pharmaceutical, Celltrion, Rituxan, Herceptin, biosimilars
The drug industry might finally have an answer for migraines
Stat
Fri, 09/23/16 - 09:52 am
Tags:
migraines, Amgen, Eli Lilly, Alder Biopharma, Teva Pharmaceutical, CGRP blockers
Teva, Perrigo and Sun join list of suitors checking out Bayer's $1.1B derm unit
Fierce Pharma
Thu, 09/22/16 - 09:46 am
Tags:
Teva Pharmaceutical, Perrigo, Sun Pharma, Bayer, dermatology, M&A
Teva, Regeneron enter deal potentially worth up to $2.6 billion to develop pain therapy fasinumab
First Word Pharma
Tue, 09/20/16 - 11:11 am
Tags:
Teva Pharmaceutical, Regeneron, fasinumab, painkillers
Teva Pharm, Intel to study Huntington disease progression
Yahoo/Reuters
Thu, 09/15/16 - 07:14 pm
Tags:
Teva Pharmaceutical, Intel, Huntington's disease, wearables
Will Teva Pharmaceuticals (TEVA) Stock Be Helped by Planned Launch of Generic EpiPen?
TheStreet.com
Fri, 09/9/16 - 09:10 pm
Tags:
Teva Pharmaceutical, Mylan Labs, generics, EpiPen
How can Teva buck industry trends for 5% yearly generics growth? Launches--and lots of them
Fierce Pharma
Fri, 09/9/16 - 05:14 pm
Tags:
Teva Pharmaceutical, generics
Can AstraZeneca plc (ADR) Asthma Drug Hold Up Against Rivals?
Bidness, ETC
Tue, 09/6/16 - 11:19 pm
Tags:
AstraZeneca, asthma, benralizumab, GSK, Nucala, Teva Pharmaceutical, Cinqair
Mylan may get the 'horns' from EpiPen competitors as pricing controversy burns hot
Fierce Pharma
Tue, 09/6/16 - 12:43 pm
Tags:
Mylan Labs, EpiPen, drug pricing, Teva Pharmaceutical, Impax Labs, MannKind
Third U.S. patent on Teva's MS drug Copaxone invalidated
Reuters
Fri, 09/2/16 - 11:29 am
Tags:
Teva Pharmaceutical, Copaxone, MS, multiple sclerosis, patents
In wake of generics deal, Teva to close New York plant
BioPharma Dive
Thu, 09/1/16 - 04:44 pm
Tags:
generics, Teva Pharmaceutical, drug manufacturing, R&D, Allergan, Actavis
How Mylan tried to keep Teva from selling a generic EpiPen
Stat
Wed, 08/31/16 - 09:13 pm
Tags:
Mylan, EpiPen, generics, Teva Pharmaceutical
Generics creep in as Teva loses two Copaxone patents
BioPharma Dive
Fri, 08/26/16 - 09:55 am
Tags:
Teva Pharmaceutical, Copaxone, patents, MS, multiple sclerosis, generics, Glatopa, Novartis, Sandoz
Will Teva Pharmaceutical Strengthen Specialty Pipeline in 3Q16?
Market Realist
Thu, 08/25/16 - 09:46 am
Tags:
Teva Pharmaceutical, SD-809, Vantrela, TV-7820, TV-46763
Why Momenta Pharmaceuticals Shares Made a Late-Day Jump Higher
Motley Fool
Wed, 08/24/16 - 05:40 pm
Tags:
Momenta Pharmaceuticals, Teva Pharmaceutical, Copaxone, patents, Mylan Labs, multiple sclerosis, MS
What Allergan's Acquisition Could Mean For Its Future
Seeking Alpha
Mon, 08/15/16 - 09:59 am
Tags:
Allergan, M&A, generics, Teva Pharmaceutical
Teva's Value Rises With Transformation Into Global Pharma Giant
Forbes
Fri, 08/12/16 - 10:00 am
Tags:
Teva Pharmaceutical, R&D

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.